Synchrony Financial (SYF) Earnings Call Transcript & Summary
April 27, 2021
Earnings Call Speaker Segments
Jennifer Church
executiveThanks, and good morning to all of you. It's a pleasure to have you join our quarterly earnings conference call. Along with the press release issued today, we've made available a presentation that addresses the subjects we intend to discuss on this call. The press release, along with detailed financial schedules and the presentation, can be found on our website, synchronyfinancial.com. You can reach this material by navigating to the Investor Relations section of that site. Before we begin, I'd like to remind everyone that forward-looking statements will be part of our comments today. Such statements carry risks and uncertainty, and actual results might differ materially. The factors that could lead actual results to differ materially are listed in our SEC filings, which you can access on our website. Throughout this call, we will reference non-GAAP financial measures when discussing how the company performed. A reconciliation of these measures to GAAP financial measures is included in our materials for today's call. Lastly, Synchrony Financial bears no responsibility for, does not edit, and cannot guarantee the accuracy of earnings teleconference transcripts supplied by third-parties. The only authorized webcast can be found on our website. Joining us this morning are Brian Doubles and Brian Wenzel. At this point, I'll hand the call over to Brian Doubles.
Brian Doubles
executiveThank you, Jennifer, and good morning to all of you. For me, speaking with you today in my new role as Synchrony's CEO is genuinely an honor and a privilege. With our solid base to build upon, I think Synchrony is positioned extremely well for the coming phase of our growth story. Momentum in this business is strong, powered by the continued rollout of our strategy along with the steadfast effort and dedication of our team. Although the year just past brought difficulties and was unprecedented in numerous respects, encouraging indicators of a rebound are beginning to appear. We are also witnessing the payoff from strategic moves we sped up and from new offerings introduced during the last year. The possibilities that lie ahead make me quite optimistic and enthusiastic, and I feel honored to steer Synchrony forward. Having said that, I want to turn to a few of the key points from our results for the first quarter. We earned $1 billion, equating to $1.73 per diluted share, which is $1.28 higher than a year ago. Our company's durability came through clearly as we made our way through the pandemic. From the core strengths of the business — ranging across varied programs and networks plus disciplined underwriting — to our capacity to respond swiftly and deliver readily integrated, seamless digital offerings, we proved that the way our business is built allows it to perform even under the toughest operating conditions. And now that we are starting to come out of this difficult stretch, many of our growth drivers have surpassed the pre-pandemic levels recorded in last year's first quarter. Significantly, purchase volume rose a robust 8% versus a year ago, and purchase volume per account jumped substantially, by 18%. Even as purchase volume trends look strong, loan receivables fell 7%, landing at $76.9 billion, because payment rates ran high after extra stimulus arrived during the quarter — though average balances per account have recovered, up 1% compared with the first quarter of last year, and new accounts likewise climbed 3%. Net interest margin dropped 117 basis points, reaching 13.98%, since additional stimulus kept pushing payment rates up, which reduced our receivable mix and yield. For the quarter, the efficiency ratio came in at 36.1%; our strategic plans for shrinking the expense base remain on schedule, with $210 million in expenses to be removed before the year is out. Credit quality kept performing remarkably well, with net charge-offs at 3.62% this quarter versus 5.36% a year earlier. Because of the liquidity and funding approach we took in response to how COVID-19 affected our balance sheet, deposits declined $1.9 billion, or 3%, compared with last year. Since we hold excess liquidity, we have been deliberately moderating the pace of overall deposit growth. Total deposits made up 81% of our funding, as our direct deposit platform continues to be a key source of funds. The digital tools and service we offer customers make our bank appealing to depositors, and we will keep expanding further capabilities. Over the course of the quarter, we gave back $328 million of capital, consisting of $200 million in share repurchases along with $128 million in common stock dividends. We still have a robust pipeline of new opportunities spanning our platforms, yet we remain highly disciplined when it comes to risk and returns, and making sure our partnerships are built with strong alignment that works well for both sides is essential. That said, as we announced earlier, we will not be renewing our partnership with the GAAP, since we could not arrive at terms that made sense for our company; we anticipate that leaving this partnership and putting that capital to work elsewhere will be EPS neutral compared with current program economics and accretive versus the proposed renewal terms. We have been on a journey to grow alongside partners who tap into our digital capabilities to help them generate sales and address the fast-evolving needs of their customers. Our capacity to win programs through transformational digital innovation has been shown by several recent wins; these capabilities are likewise essential to the success of every one of our programs, since consumers are quickly embracing technologies that make contactless commerce possible and anticipate engagement throughout their digital purchase journeys. We are drawing on our extensive digital assets together with our robust data analytics capabilities to make the whole consumer experience more personalized and meaningful. We have kept broadening our digital penetration throughout the customer journey, from apply, to buy, to servicing. Roughly 60% of our applications were completed digitally in the first quarter, and we posted 14% growth in mobile channel applications. In retail card, 50% of our sales took place online and about 65% of payments were made digitally. The investments we are making in digital and data analytics keep delivering results. Over the quarter, we renewed 10 programs, among them American Eagle, Ashley Homestore, CITGO and Phillips 66. We also brought in 10 new programs, among them Prime Healthcare, Mercy Health and Emory Healthcare, which advances our penetration of health systems. And we are also broadening the utility of our CareCredit card. Our patient financing app is now offered on the Epic's App Orchard. This makes CareCredit available to hundreds of health care organizations that use Epic's MyChart and lets cardholders use CareCredit to cover co-pays, deductibles and medical expenses not covered by insurance. This technology integration not only offers a way to boost the usage and acceptance of CareCredit, but also helps health services and hospital providers operate efficient, financially healthy organizations by helping to improve revenue cycle management and reduce debt risk. We are excited about the prospects to support patients beyond elective care as we expand to offer payment options for nonelective medical expenses and routine care. I'll take a few minutes today to outline our CareCredit strategy and provide a framework for thinking about the opportunities that lie ahead. For a number of years now, we've been reshaping CareCredit so it serves as a fuller answer for financing and payments tied to consumers across health care, pet care and wellness, doing so by broadening the ties we hold with providers, retailers, payers and pharmacies; in this area, our scale and depth are unmatched. We have $9.3 billion of receivables along with acceptance at roughly 250,000 enrolled provider, health and wellness retail locations. More than 8 million cardholders use the card; we're present in over 80% of dental offices across the nation and in more than 40 health care specialties, 13 of which have been added since 2018; we perceive substantial opportunity among health systems and hospitals, and our reach has grown quickly through the launch of 8 new programs in 2020, lifting our total to 13; as our pet vertical has grown, we now sit in over 85% of vet practices, and pets in force have risen by 174% since we acquired the Pets Best insurance business 2 years ago. A major driver of our success is how engaged our cardholders are. They rate us highly, with our customer satisfaction score having climbed to 92% from 78% back in 2009. Our Net Promoter Score stands at nearly double the credit card industry average. And as evidence of how much cardholders value the card, we've managed to push repeat sales up to nearly 60%.
Brian Doubles
executiveThat speaks to the effort we've devoted to building a compelling value proposition for the card and enhancing its usefulness as we expand our network one office and one provider at a time. Those efforts, along with where we sit in this market, are reflected in our growth figures. Over 7 years, our receivables are up 44%; during that same period we broadened the business as well, with provider locations rising 41%, and active accounts now total 5.7 million — again a double-digit gain across 7 years. An extraordinary platform for growth has been created, and as we map out the road ahead we occupy an enviable spot, continually evolving to seize additional opportunity. Dental, veterinary and specialty industries still offer enormous room for further growth. Investments are underway to streamline the experience for customers and providers, and we're using technology to enable more consumer-driven, self-service options. There's plenty of space to grow by deepening penetration with partners we already have and through innovation that makes engaging with our network ever easier. Not long ago we bought Allegro Credit, which has simultaneously deepened our reach in audiology and other industries and made new products and capabilities possible. As out-of-pocket health care costs keep climbing and high deductible health care plans remain popular, consumers are taking on a greater share of the financial responsibility for their care. That adds up to a major opportunity — over $405 billion in out-of-pocket health expenditures in the U.S. — yet flexible and extended financing represents just a small piece of overall health care payments, leaving considerable runway for growth; we're also moving past the traditional care credit industries and seizing on the shifting health care landscape, which places greater emphasis on overall wellness. No longer limited to elective care financing, we now help patients pay for nonelective medical bills, planned procedures and routine medical care as we move into health systems and additional health care specialties; ongoing integrations with practice management software, plus the recent news that CareCredit is available through Epic's App Orchard, will strengthen this. We've also broadened our utility by creating more ways to reach health care services through partnerships with pharmacies. CareCredit is accepted at over 17,000 pharmacies across the nation already, and we recently announced that we'll become the issuer of the Walgreens co-branded credit card program in the U.S. — the first credit program of its kind in the retail health sector — with the new program expected to launch in the second half of 2021; we're also reshaping our pet business into a more comprehensive financial solutions provider that serves pet parents across their entire pet care journey. Americans are more devoted to their pets now than ever before. Pet ownership has risen a lot, and so have costs, across the last several years, and during the pandemic that pattern accelerated even further — Americans lay out over $100 billion on pet-related spending. Beyond that activity there's a sizable market presenting a major chance to deliver fresh offerings, financing choices, and services. CareCredit backs a pet's care throughout its life, and thanks to buying Pets Best insurance, we right now provide a complementary answer alongside veterinary care that helps pet owners with straightforward, adaptable financial solutions. We keep working to fold the Pets Best insurance product in so we can capture the payment and customer experience synergies; beyond that, we're exploring paths to move into additional pet adjacencies via retail products and services. By concentrating on what our partners and customers need while supplying considerable scale and know-how, we think we'll build loyalty toward the CareCredit network and consequently ought to achieve outsized growth down the road. Having said that, I'll hand the call over to Brian.
Brian Wenzel
executiveThank you, Brian, and good morning to all; we're in a crucial stretch for both our organization and the globe as we keep moving past the pandemic. The way our business stands and the steps we've implemented during the last 12 months put us in a strong spot to seize the possibilities in front of us. I echo Brian's feeling of gratitude for the steadfast dedication of our team members. My thanks go out to everyone engaged in creating, distributing, and managing vaccines that assist us in getting through this incredibly challenging time. Now I'll give an update regarding our results for the first quarter. Over the last 12 months, the pandemic along with the government stimulus measures it triggered have affected multiple critical parts of our operations. Even so, the composition of our business has allowed us to lessen certain pandemic effects, since some segments have done quite well, such as digital offerings, home-related goods and services, veterinary care, electronics, and appliances. Results in those segments have offered a buffer against the broader consequences of the economic slump. As we finish the first quarter, we're beginning to observe stronger indications of a wider economic rebound. Purchase volume rose 8% compared to the previous year and came in above what we had anticipated for the quarter. Looking at the macroeconomic picture, consumer confidence hit a 1-year peak during March, unemployment kept getting better, and certain remaining local restrictions started to loosen. This shows up in the growth of purchase volume per account, which has climbed 18% compared to last year. The average number of active accounts fell 8%, signaling a deceleration in the pace of decrease that is still being affected by the macroeconomic consequences of the 2020 pandemic and the uneven recovery seen in the first quarter. We did open more than 5 million new accounts, which is a 3% rise compared to first quarter 2020, a good indicator that mirrors better consumer sentiment. Loan receivables dropped 7%, a result that fell short of what we expected. The reason behind this was a larger-than-anticipated rise in payment rates, mostly caused by the stimulus that was recently put into effect. Interest and fees on loans fell 14% compared to last year, pushed by the heightened payment rate along with reduced delinquencies. Dual and co-branded cards made up 38% of purchase volume during the first quarter and grew 6% over the prior year. When looking at the loan receivable basis, they represented 23% of the portfolio and dropped 10% from the prior year. All in all, we witnessed favorable momentum across several of our growth metrics this quarter, though the increased payment rates are affecting the expansion of loan receivables. That said, we're still careful regarding the pandemic's status given the recent uptick in confirmed cases. We take encouragement from the headway made in the national vaccine rollout and the removal of certain remaining restrictions; we stay hopeful about the positive momentum and ongoing enhancement as we move through 2021. RSAs went up $63 million, or 7%, from last year. RSAs expressed as a percentage of average receivables came to 5.1% for the quarter. That came in above what we'd normally see historically, and the main driver was a big gain in net charge-offs. Our loan loss reserves came down this quarter, reflecting a better macroeconomic picture along with a reduction in loan receivables. That, together with lower net charge-offs, produced a sizable drop in the provision for credit losses — $1.3 billion, or 80%, compared with last year. Other income was up $34 million, largely on investment income. Other expense fell $70 million, or 7%, versus last year, on lower operational losses and reduced marketing costs, partly offset by higher employee costs. Turning to platform results on Slide 9. Pandemic restrictions and elevated payment rates are still hitting our sales platforms to differing degrees. How they've performed has varied depending on things like business and partner mix, digital concentration, provider access and availability of hard line goods. Purchase volume has shown broad-based momentum as consumers grow more confident with the pandemic winding down. In retail card, loan receivables were down 9%, yet momentum showed through with purchase volume up 11% against last year. Average active accounts fell 7%, and interest and fees dropped 16% because of the pandemic's impact. We're thrilled about our new American Eagle program and still see a big opportunity in our recently launched programs with Verizon and Venmo as those ramp up. Strength in our powersports and home and specialty and payment solutions continues to help offset some of the hit from pandemic shutdowns and higher payment rates. Loan receivables declined 1% in the quarter, average active accounts were down 9%, and interest and fees fell 11%, driven mainly by lower late fees, finance charges and merchant discount, all stemming from the reduction in loan receivables; purchase volume did show positive momentum, rising 3% over last year. Our push to grow this platform led to several new programs being signed and key partnerships renewed, among them Ashley Home Furniture during the quarter. We keep driving organic growth through our partnerships and networks and brought on more than 3,900 new merchants during the quarter. We're also continuing to drive higher card reuse, which now sits at about 34% of purchase volume, excluding oil and gas. CareCredit took the biggest overall hit from pandemic restrictions, but this platform has kept improving into 2021 as providers have brought back elective and planned services from the trough in the second quarter of last year. That improvement shows in our purchase volume being flat to last year. Loan receivables were down 8% this quarter and drove a 7% decrease in interest and fees on loans as we recorded lower late fees and merchant discounts. During the quarter, we continued growing our CareCredit network and enhancing the utility of our card. Our acceptance and network growth initiatives allowed us to push the reuse rate up to 59% of purchase volume during Q1. That represents a strong engine for expansion in our company, and we're still enthusiastic about chances to generate additional growth once the effects of the pandemic fade. Turning to Slide 10, I'll discuss trends in net interest income and margin. Recently passed stimulus measures caused payment rates to rise during the quarter — roughly 2 percentage points above the average payment rates we saw before the pandemic. In March, when the latest stimulus package became law, that gap reached as much as 3.5 percentage points. Loan receivables have consequently shrunk, which affected net interest income and net interest margin in Q1. Net interest income fell 12% versus a year ago, pushed down by reduced finance charges and lease fees. Net interest margin came in at 13.98%, versus 15.15% in the prior year, mainly because of the pandemic's effect on loan receivables plus greater liquidity and lower benchmark rates. More specifically, the loan receivables yield was 19.32%, a decline of 135 basis points year over year, and that was the main factor behind the 117 basis point drop in our net interest margin.
Brian Wenzel
executiveLoan receivables, as a share of total earning assets, fell by more than 3 percentage points, moving from 81.7% down to 78.6%, which came about because we held more liquidity during the quarter. That shift was responsible for 61 basis points of the drop in net interest margin. Lower benchmark rates pushed the liquidity yield down, and that accounted for a 23 basis point reduction in net interest margin. Partly offsetting these effects was a 93 basis point drop in the cost of total interest-bearing liabilities, which fell to 1.57%, mostly because benchmark rates were lower. That gave us a 78 basis point lift to net interest margin. We still expect that during the second half of the year, excess liquidity will start being put to work in asset growth, and moderating payment rates ought to produce stronger interest and fee yields, which should push net interest margin higher. Now I'll move on to key credit trends, which are on Slide 11. As for what happened specifically this quarter, let me begin with delinquency trends. Our 30-plus delinquency rate came in at 2.83%, versus 4.24% a year ago. The 90-plus delinquency rate stood at 1.52%, against 2.10% a year ago. Continued higher payment rates are fueling these delinquency improvements. Turning to net charge-off trends. Net charge-off rate was 3.62%, compared with 5.36% a year ago. The decrease in our net charge-off rate came mainly from better delinquency trends, since customer payment behavior has improved across the last several quarters. Allowance for credit losses, as a percent of loan receivables, was 12.88%. On Slide 12, I'll go over expenses for the quarter. On the whole, expenses came down $70 million, or 7%, versus a year ago, landing at $932 million, as we keep executing our strategic plan to cut costs. More specifically, the drop came from lower operational losses along with reduced marketing and business development costs, partly offset by higher employee costs. The efficiency ratio for the first quarter was 36.1%, versus 32.7% a year ago. Lower revenue weighed on that ratio, stemming from reduced receivables and a lower interest and fee yield, which was partly offset by an expense reduction. Turning to Slide 13. Because our loan receivables have come down and our deposit platform is strong, we keep carrying a greater amount of liquidity. Although we think holding more liquidity is wise while conditions are uncertain and volatile, we are actively managing our funding profile so we can mitigate excess liquidity where it makes sense. This strategy produced a change in our funding mix during the quarter. Deposits were down $1.9 billion versus a year ago. Securitized and unsecured funding sources decreased by $2.1 billion. As a result, deposits made up 81% of our funding, versus 79% a year ago, while securitized funding was 9% and unsecured funding was 10% of our funding sources at quarter end. Total liquidity, including undrawn credit facilities, reached $28 billion, equal to 29.2% of our total assets, up from 25.3% a year ago. Before I get into the specifics of where our capital stands, I want to note that we made the choice to utilize the transition rules put out by the joint federal banking agencies, and that comes with 2 main advantages. The first is that it pushes back the impact of the CECL transition adjustment by an additional 2 years; the second is that it permits proportionate provisioning for the current period to be postponed and then amortized along with the transition adjustment. Under this approach, we closed out the quarter at 17.4% CET1 under the CECL transition rules, which is 310 basis points higher than the 14.3% we recorded a year ago. On the Tier 1 capital ratio, we stood at 18.3% under the CECL transition rules, versus 15.2% in the prior year. Our total capital ratio rose 320 basis points to 19.7%; meanwhile, the Tier 1 capital plus reserves ratio, on a fully phased-in basis, climbed to 28.7%, up from 24.1% a year earlier, which mirrors the growth in reserves stemming from CECL implementation. Over the quarter, we gave back $328 million to shareholders, consisting of $200 million in share repurchases along with a common stock dividend of $0.22 per share. Because the operating environment remains uncertain, I figured it would be useful to offer some perspective on how we currently see the main earnings drivers for 2021, which are shown on Slide 14. Our assumptions factor in that pandemic-related pressure and a sluggish economic rebound persist through the second quarter, followed by the second half in which the pandemic is mostly contained and the economic recovery speeds up. First quarter purchase volume came in above what we had expected when the year began, since local restrictions have been easing, consumer confidence has been rising, and so has consumers' willingness to spend. At present, we think these patterns will persist and purchase volume will keep recovering across all our platforms. When we get to the second quarter, the comparison will be against a stretch of broad shutdowns. In the second half, we expect growth trends to improve as the pandemic's impact fades and macroeconomic growth picks up. Turning to loan receivable growth. We anticipate that stimulus will keep influencing payment rates, and as a result, loan receivables will be affected into the following quarter. For the second half of 2021, our assumption is that payment rates will ease as stimulus effects diminish and consumer payment behavior patterns go back to something more typical. When we combine that with the anticipated rise in purchase volume brought about by a better macroeconomic backdrop, it ought to help drive loan receivable growth. On net interest margin, we think the elevated payment rates will keep weighing on loan receivables and create excess liquidity, which affects interest and fee yield as well as asset mix. Our view remains that excess liquidity will shrink through asset growth and decelerating payment rates in the latter half of the year, and that will fuel better interest and fee yields and asset mix, resulting in a rising net interest margin. When it comes to credit, we anticipate delinquencies will climb above where they stand today, though our current view is that the peak will arrive later than we originally expected — most likely in early 2022. Even though delinquencies at present will translate into reduced net charge-offs during the second quarter, we anticipate net charge-offs will increase because of rising delinquencies as 2021 progresses. Considering how much stimulus went into the system throughout the pandemic, our belief is that the loss curve overall will end up flatter than our initial expectation, yet it stays volatile and hard to predict now that the impact of that stimulus and of industry forbearance has worn off. We anticipate reserves will mostly be shaped by asset growth, the effect of any credit changes and our macroeconomic assumptions, and particular combinations of those factors might lead to additional reserve releases during this year. Into the second quarter, we expect RSAs to stay elevated, mainly because of strong program performance, which includes better net charge-offs, partly offset by reduced revenue. During the year's second half, we still expect RSAs to be lower in general, which reflects higher net charge-offs, partly offset by greater revenue. As we described earlier, cost reductions have been put in place throughout the organization, and I'm happy to say that we are on track to hit our expense savings goal of $210 million for the entire year.
Brian Wenzel
executiveWorking against those savings, we'll see higher expenses tied to expansion, plus the rise in delinquent accounts we expect. Our team will keep a close watch on the pandemic's path and what it does to the broader economy. Deep down, we believe we're positioned well to seize the opportunities that emerge as the recovery gains a firmer footing. On top of that, we've put the investments in place to help our partners, who've had to overhaul their operations quickly to keep up with new digital realities; and we'll keep investing in our people, products, technology and platforms so we can drive long-term value, keep our employees safe, and still serve the needs of our partners, merchants, providers and cardholders. With that, I'll hand the call back to Brian for his closing remarks.
Brian Doubles
executiveAppreciate that, Brian. Let me give you a brief run-through of the main themes from this quarter, and after that I'll hand things over so we can get into Q&A. Obviously, the pandemic has delivered major consequences and in numerous respects has transformed the manner in which we conduct business. What became clear during this quarter is that we're starting to come out on the opposite side of that stretch. The mood among consumers has gotten better, joblessness has come down, and retail sales in the U.S. recorded their biggest increase in 10 months. Our company is demonstrating its durability, with growth picking up as purchase volume climbed 8% and 5 million new accounts were opened during the quarter. And even though those strong growth figures got held back by elevated payment rates, which weighed on loan receivables and NIM, we expect these headwinds to fade before long. Credit performance keeps surpassing expectations, and we're still growing our CareCredit network, rolling out new products, financing alternatives and experiences, with an emphasis on overall wellness and pet. The key takeaway is that we proved our capacity to adjust quickly and function in a fresh environment while still keeping our focus on the long term, setting ourselves up nicely for what lies ahead; and as I see it, we've never been in a better position. I'll hand the call back to Jennifer now to kick off the Q&A.
Jennifer Church
executiveThat wraps up what we had to say about the quarter. At this point, we'll move into the Q&A portion. To give as many of you a chance as we can, I'd ask those joining to keep it to 1 main question plus 1 follow-up. Should anything further come to mind, the Investor Relations team will be around once the call ends. Operator, go ahead and open the Q&A.
Moshe Orenbuch
analystThank you. Brian, I was wondering if you might take a brief moment to talk about this going back to normal when it comes to things like late fees, and how that has impacted the net interest margin and the timing, and perhaps prepay speeds as well — for instance, what are the actual — setting aside the stimulus injections, the ongoing effects, how should we think about the timeline for both of those to return to something near normal?
Brian Doubles
executiveThanks, Moshe. So yes, clearly, we've dealt with the headwind related to stimulus. We saw cash flow genuinely start back in mid-March, right around the fourth week after stimulus started to arrive. So starting then, we continue to observe higher payments. As we get deeper into April, those are starting to come down a bit. Obviously, tax refunds are a converging element here. So stimulus is definitely the top factor. If you look at the late fee yield and went back to check how many delinquent accounts we had, those are more than 30% lower than in the '19 period — that's before the pandemic. So once more, when you think about net charge-offs rising or simply things getting back to normal in the charge-off environment, that late fee yield is going to return to the book, and it will arrive before the charge-offs actually hit. We'd anticipate that yield starting to climb during the second half of the year. Moshe, here's what I'd add: since so many people zero in on the business's margin, we sit at 14% right now. Our guidance has pointed toward roughly the 16% area once conditions normalize. Let me unpack those pieces briefly — the initial component is really the excess liquidity I mentioned at the outset, tied to the stimulus factors, correct? So, had you gone back and examined excess liquidity before the pandemic, then applied it against today's book, you'd likely gain somewhere around 90 basis points on net interest margin. Earlier we mentioned that benchmark rates likely carry roughly 25 to 30 basis points, though how prime performs remains to be seen. The remaining portion—primarily yields from late fees and interest—will return to the portfolio and materialize. So I believe a path is visible where this starts picking up speed during the latter half of the year and moves toward what's typical for us as we head into '22.
Moshe Orenbuch
analystGreat. And as a follow-up, you brought up those 5 million new accounts. My assumption is that's still happening alongside somewhat slow retail openings — could that figure improve? And is there anything new you can share regarding the Verizon and Venmo programs in particular?
Brian Doubles
executiveYes. Moshe, Brian Doubles here. We would definitely anticipate that figure continuing to climb; at present we aren't operating in a completely open economy. As you're aware, I believe there are — well, plenty of grounds for optimism. When you examine the consumer, you examine employment trends, unemployment returning to 6%, plus consumer balance sheets remain solid and they're beginning to spend once more. I believe the reality that we recorded 8% purchase volume growth along with 11% of retail card is a genuinely encouraging signal. Yet that isn't where things ought to stand in a fully operating open economy; therefore I believe there's still room across every growth metric to advance beyond this point; we remain in the early innings when it comes to a recovery. Still, the majority of trends we're observing are fairly encouraging. The reality that we increased purchase volumes per account by 18% is a genuinely strong signal that consumers are spending once more. And I truly believe that will translate into greater revolving behavior eventually. What I mean is, the impact of the stimulus, as Brian mentioned, is going to — it's going to fade with time. I believe you'll begin noticing that fairly soon as confidence improves, you typically see consumers take on additional debt and revolve somewhat more, which will assist with balances and margins too.
Brian Wenzel
executiveOne more point to mention, Brian, when you're looking at originations from new accounts: the credit box remains untouched. My view is that as we keep progressing through the year, we're applying credit refinements aimed at expanding credit, though no acquisition activity has taken place. That too should act as a tailwind as the year unfolds, Moshe.
Brian Doubles
executiveNow, Moshe, regarding both Venmo and Verizon — there's plenty of reason for enthusiasm around each of those initiatives. With Venmo, we're still in the early days, yet new accounts and spend have exceeded what we anticipated. Customer reaction to the card has simply been extraordinary. They're thrilled with the value proposition, plus the way it automatically figures out the best rewards for whichever categories you spend the most in. The card's design and the QR code get a lot of love too. So the response has been fantastic. As for Verizon, which is somewhat further along, purchase volume looks really strong. It's clearly acting like a top-of-wallet card, exactly as we'd hoped. Both are doing well so far. And my belief remains that each could become a top 10 program for us down the road.
Sanjay Sakhrani
analystI'd like to build on what was said regarding growth in loans. When I consider your framework and the outlook covering this year, do you feel more positive about expansion in loans as we look at what remains of the year? Then, regarding that off-line recovery specifically, are you expecting an offline rebound since it appears it would affect that loan growth more heavily than other areas?
Brian Wenzel
executiveCorrect, Sanjay. Correct, when we consider growth in loans, we came into the quarter feeling good about how we were positioned. Coming out of the quarter, we're likely somewhat more upbeat than that. Thus we've witnessed a wide-ranging rebound when looking at retail card, which rose 11%; that reflects both growth of digital plus a portion of what you refer to as off-line. Retailers sort of entering the picture. From a receivable perspective, I believe we're observing robust volumes. A portion of that is clearly supported by stimulus funds that arrived in March. Yet we observed momentum during every month of the quarter. So it exceeded our expectations. And when I consider growth in loans, I believe you'll likely witness a turning point in the second quarter, with acceleration toward the later portion of the year; so I do believe you'll see favorable trends emerge within the portfolio. And once more, we have tailwinds that remain present in the CareCredit platform, correct, since you have dental implant services reopening and you still have supply chain problems in the payment solutions platform; therefore many tailwinds exist beyond what we've already observed. So once more, we're hopeful regarding our position and how the second quarter will unfold and what we've observed so far this quarter and then how the latter half of the year appears.
Sanjay Sakhrani
analystGreat. And to build on that, Brian Doubles, perhaps you could elaborate a bit on the GAAP relationship loss and how you expect it to impact the broader industry, given that newer entrants are arriving and may engage in some aggressive pricing moves. In other words, how do you believe that shapes the future pipeline? And are there deals in your pipeline that strike you as interesting?
Brian Doubles
executiveYes. Thanks, Sanjay. Look, I believe this was a somewhat unique case. I'd say we enjoyed a genuinely solid partnership over a number of years. In fact, we received excellent feedback from the client regarding our partnership approach, our products, and our capabilities. Ultimately, though, this one simply boiled down to terms and price. And our competitor was simply far more aggressive on both fronts. There were certain, I'd describe them as truly out of market terms, in which they sought guaranteed revenue that rose annually no matter how the program performed; and for context, given the turnaround they've been working through, the program had been shrinking. And so there's really only so far you could go to guarantee those types of payments on a program like that. So look, we attempted to reach an agreement. In the end, there just wasn't a way for us to get our interest aligned; but I do think this is a pretty unique situation. I look at the pipeline today across all 3 platforms; we've got really attractive opportunities with very strong partners at attractive returns, where our interests are aligned; and I think that is so important; we talked about this for a number of years. We want programs where our interests are aligned in growing the program. We're doing that in a way that benefits both parties; so I still feel really good about the pipeline as I look across all 3 platforms.
Ryan Nash
analystOkay, Brian, your CET1 ratio stands at 17.4%. Looking at this quarter, you made more than $1 billion. Reserves are probably declining. And despite growth returning, you'll probably build capital over the next few quarters, even with that $1.6 billion buyback already in place. So I wanted to ask, could you perhaps discuss the plan for bringing CET1 back up toward where peers are? And might there be a chance you'd reconsider your capital return for upcoming quarters?
Brian Wenzel
executiveYeah. Appreciate it, Ryan. Clearly, during Q1, we bought back $200 million worth of stock, which fell under that $1.6 billion authorization we told everyone about back in early January. And for some context, when we approached the Board and talked it over with them, that approval happened around December, based on the models. As the quarter progressed, we obviously gained additional data. We refreshed our scenarios, sent our capital plan to the Fed in March, and expect to hear back from them later in this quarter. So we'll find out what those results show, though we feel good about their backing of our capital plan. We're well aware, Ryan, that we're holding surplus capital, and Q2 will once more fall under Fed restrictions, which limit us to roughly $390 million in buybacks for this quarter. My assumption is we'll hit that ceiling, assuming market conditions allow. After that, we'll circle back with you to discuss the capital plan we filed with the Fed. That said, should the business's income profile shift, we didn't address anything related to GAAP in that capital plan, and if the portfolio suggests we should, we might revisit it and return to the Fed if it makes sense. So we'll keep having those conversations with the Board and, of course, with our regulators. So an opportunity does exist. On your question about pacing, we clearly aim to return to our long-term objective of matching peers, and we'll get there as carefully as we can; but naturally, we want to have everyone's backing to do so. Nothing stands in the way of that. We simply want to proceed sensibly. And certainly, we're not entirely finished with pandemic-related care, but we'll act as cautiously as we can to get that done.
Ryan Nash
analystUnderstood. And perhaps, simply as a quick reasonableness check following up on what Moshe asked, how ought we to consider the tempo of NII enhancement compared with the tempo of loan expansion, taking into account all the margin dynamics plus the gradual credit normalization. Once we observe those elements fading, ought we to expect NII to substantially outstrip loan expansion as things normalize?
Brian Wenzel
executiveYeah. My inclination would be to view it as progressing more in sequence as of — during the initial portion of this quarter. By the time you reach the latter portion of the year, once the late fee yield begins showing up, you might witness NII speeding up somewhat more rapidly, though that will genuinely hinge on the delinquency formation, Ryan.
Betsy Graseck
analystI've got a few things to ask. First, regarding the capital targets, can you help us understand what you'd consider the optimized level for your firm across the coming cycle? Part of why I'm asking is that I want to grasp how you plan to think about your capital when it comes to funding loan growth. Or, looking at it from the other direction, do you believe your loan growth can be entirely funded through the shift in your liquidity mix? So some detail on that would be useful.
Brian Wenzel
executiveSure. I'll take the second half of what you asked first. Obviously, the extra liquidity on our books, in our view, carries us through the loan growth we anticipate showing up in the portfolio, which, as we've said, returns to a more normalized level in the back half of the year; we've mentioned a possible acceleration as we move into 2022 given pent-up demand. And we think that extra liquidity is more than sufficient to back that up. And certainly, given the earnings power of the business we're expecting this year from a capital perspective, we ought to be in a position to support it. As for the first half of what you asked, regarding those targets. I mean, we reference peer targets, so when you consider the Cap One's, this lands in that 11 to 12, perhaps 10.5 range. We'll watch how the portfolio evolves. We're hopeful we can reach that within a sensible timeframe. I think if you look back, we left GE at 18%. We brought it down to 14% prior to the pandemic arriving. And we believe we can return there within a fairly sensible timeframe. And if you recall, just before the pandemic arrived, we were on track to carry out a $3.6 billion capital plan. We're $3.3 billion into it; so we think we can deploy it pretty quickly once we're comfortable.
Betsy Graseck
analystAll right. And Brian, near the start of this call you brought up CareCredit. Could you perhaps walk us through what the Walgreens portfolio will mean over time? I believe you said Verizon and Venmo could become top 10 programs, so maybe you can share how you're viewing Walgreens? Also, what should we expect regarding CareCredit's effect on RSAs? Does it work the same way the retail program does, or are there distinctions we ought to know about?
Brian Doubles
executiveSure thing, Betsy. Well, CareCredit, to me, is likely the single most exciting growth opportunity we currently have as a company. We attempted to show that across a few slides. First, we're targeting a market of this size that's expanding at such a rapid pace. Naturally, health care costs keep climbing, and high deductible plans keep gaining popularity. That means insurance covers less and less, which is exactly where CareCredit fits in; we're a major participant in this space right now, yet financing options here remain a very small portion of the potential spend available. So there's simply an enormous amount of room to grow; and I view that growth as having really 3 components. One is expanding the core, where CareCredit is currently accepted at roughly 250,000 locations. We operate across 40 different specialties; we added 10 new specialties within just the last 2 years. And we're in 80% at dental offices, 85% of that. So we have considerable scale. Even so, there's still plenty of room to increase penetration among those providers, since third-party financing options remain a comparatively small percentage; so lots of room to grow there; and then we discussed both health systems a bit; we're in 13 large health systems today; that's an expanding portion of our business. We're partnered with major names such as Kaiser Permanente, Cleveland Clinic. And then we discussed pets as really that third leg of the strategy; we're experiencing truly incredible growth in our pet insurance business that we acquired a couple of years ago, up 174% since we bought it. So there's plenty to be excited about. And then you brought up Walgreens. We had — our CareCredit cards were accepted at Walgreens; we broadened that relationship to launch a new program and I think similar to Venmo and Verizon, this can be a top 10 program for us. And we're reaching 90 million myWalgreens customers. So the opportunity is simply huge. And we're actively working to get that launched in the second half of the year.
Betsy Graseck
analystAll right. And regarding the RSA — my apologies, please continue, Brian.
Brian Doubles
executiveAs you can observe — Betsy, the RSA is going to function much like what you witness happening within the retail card platform. Therefore, for Walgreens, it would be a comparable form of alignment.
Betsy Graseck
analystUnderstood. And might you ever pursue the chance to serve individual doctor practices for their own personal requirements? Or will this remain at the business level? Just curious.
Brian Doubles
executiveYes. No; when it comes to funding the practice itself, Betsy?
Betsy Graseck
analystRight, that's it.
Brian Doubles
executiveCorrect. Correct — that's a connection we've examined before, and it's shown on the screen. Right now we have no plans set to move into that space, though it's certainly a topic worth thinking about down the road.
John Hecht
analystI suppose, to expand on that just a bit. You clearly put emphasis on CareCredit during your prepared remarks. And you mentioned the scale. Could you perhaps provide an update — from the standpoint of competitive positioning, you are far bigger than whoever is second, but maybe you could discuss the competitive landscape. And considering how much momentum there is behind it, how much larger could CareCredit become as a share of, say, loans receivables in the coming years?
Brian Doubles
executiveSure, John, in all likelihood we are the largest participant in this area doing what we do. That said, competitors have entered and exited this area over the years. I really like having the scale we possess; building that level of scale and becoming embedded across 250,000 locations has required decades. So I would anticipate outsized growth for CareCredit compared with the remainder of the business moving forward. Therefore I certainly believe it will represent a larger portion of the business in the future. We are also raising how much we invest in CareCredit. Clearly, we have put in a considerable amount across the last 10 years. However, I would note that more recently, through acquisitions and pet insurance — we just acquired Allegro Credit not long ago — we are clearly seeing many chances to deploy capital both organically and inorganically, which I believe will simply speed up the growth rate here compared with the remainder of the business.
John Hecht
analystAll right. And then you folks mentioned some favorable patterns regarding the accounts you've brought on lately. Still, it's obvious that some attrition has occurred, just as it always does within the portfolio. Has anything shifted in the traits of where that attrition is originating?
Brian Wenzel
executiveYeah, John, nothing looks unusual to us, I'd say. Obviously, with more conventional retail reopening, we're seeing a surge in that area and somewhat among the walk-in customer base, yet no genuine basic changes are taking place.
Don Fandetti
analystBrian, clearly there has been a significant surge in fintech firms. I was simply wondering, when you consider your 3 businesses, is there one — or how might you order them regarding which ones you're monitoring more intently? Also I'd be curious about CareCredit. It appears that one might be more vulnerable to fintech competitors perhaps compared to other segments, though I could be mistaken about that. Just want to hear what you think.
Brian Doubles
executiveYes. No, listen, I believe you cannot confine it to merely one of the platforms. Clearly, this is an extremely competitive arena at present. The fintech sector shifts constantly, and we must remain fully engaged with it throughout all 3 of our businesses. And I believe the team is performing quite well at that; so I don't believe we experience it more sharply in one segment versus another. What I think we typically encounter from fintechs is that they usually excel at a single thing; and that's a privilege they possess. And we are — because of our size, we must excel at many things in order to rival them. But I sense that we are accomplishing that throughout all 3 of our platforms. So listen, rivalry is beneficial ultimately; it pushes us to improve. I don't sense that we are losing — I don't sense that we are losing share in any of our 3 platforms. We still have plenty of room for expansion, but it's something we must remain fully engaged with. Our teams monitor this. They are communicating with our partners. And when they observe entrants arriving in the space, we are trying our hardest to prevent them and strengthen our relationships. So I feel quite confident about our competitive positioning. But you can never become complacent, you must remain fully engaged with this.
Don Fandetti
analystYes. Then, regarding the fact that you haven't really altered credit underwriting standards, it appears a few competitors have begun to ease theirs. Is your approach simply prudence, or do you still require something before you feel at ease?
Brian Wenzel
executiveNo. Don, here's how I'd frame it: we've already begun making adjustments to our credit underwriting. As you may recall, when the pandemic first hit, our tightening leaned toward proactive forms of credit extension. We lowered the cutoff for our private label and dual card product mix; we cut back on proactive credit line increases. We also scaled back invitations to apply and prescreen offers for new accounts. Moving into 2021, what we began doing is, in cases where customers are obviously already known to us, unwinding a great deal of that credit refinement. So we're moving the cutoffs, meaning more individuals will receive a dual card, which carries a somewhat higher line, and that will certainly spur some spending out there. We've launched several credit line increase programs aimed at customers whose credit behavior and payment behavior patterns we already know. Beyond that, we've started upgrading accounts from private label to dual card for people who would have been eligible for dual card 12 months earlier; so we're acting proactively on a number of fronts; the one thing we haven't done is touch anything at the point of acquisition, like changing cutoffs; though once again, we didn't do much of that during the prior year. So I don't anticipate many changes on that front right now, but proactive increases have indeed started. And the positive part is that, thanks to our portfolio, we can extend those to customers we know, and in our view we aren't assuming incremental risk.
Rick Shane
analystSo, considering what private label is really like, you tend to find behavior that clusters more by category than what you'd see in something like general purpose. As you look ahead to spots where there's room for additional rebound, how would you say the portfolio and the opportunity indexes stack up against that?
Brian Doubles
executiveYeah, Rick, I'd say the best frame is that you need to consider — I'm aware that clearly, T&E has taken a major step back. Our concentration there is somewhat lower. Still, without a doubt, our dual cards stand to gain from that, and our general purpose card stands to gain from that too. And given that physical locations are reopening, I'd say we're definitely in a strong spot to gain from that. Beyond that, honestly, the digital patterns from the prior year, even though we'll face some difficult comparisons, those are arriving across the coming quarters. My sense is a portion of that movement was definitely lasting and will persist, and we'll gain from it too. So, taking the whole portfolio into account, the thing I reflect on fairly often, and we hear it from every one of our partners, including all the providers in CareCredit, is that there's genuine pent-up demand, correct, for essentially everything; this built-up urge to spend and return to normal. We're speaking with our providers in CareCredit, and they're unable to keep pace with the appointments. That's because so many individuals during the prior year put off things that weren't essential, they were reluctant to enter the practices. And at this point you're watching all of that begin to flow through. So I'd say no matter the category, there's an enormous amount of pent-up urge to spend. And I believe that if travel, entertainment, dining, those areas rebound, I think that additionally drives other kinds of spend that we'll observe both on our dual cards but also in certain of our adjacencies.
Brian Wenzel
executiveBrian, I'd add that, as you mentioned, our reach is extremely wide. Take the retail card segment, for example — it grew 11% during Q1. Consider how many lifestyle and specialty brands fall under that: not just American Eagle, but also DICK'S Sporting Goods. Then there are the value-focused merchants like Sam's Club and TJX included there too. Our coverage of where spending occurs is remarkably extensive, and honestly that serves as a pretty solid tailwind as we emerge from this stretch.
Rick Shane
analystUnderstood. That is quite useful. Also, Brian, you raise a genuinely intriguing idea regarding CareCredit, and that prompts my next question: do you believe specific spending categories convert inherently into a greater share of borrowing?
Brian Doubles
executiveA greater share of borrowing — is that the phrase you used, Rick?
Rick Shane
analystYeah, so take gas cards, for instance — folks might be less likely to carry a balance on one of those. But if the purchase is bigger, the kind you'd run through CareCredit, you'd definitely see more revolving.
Brian Doubles
executiveYeah. No question, with some of those larger ticket items, we'd anticipate seeing that in CareCredit. The revolve rates we see there tend to be quite strong. And honestly, I think the ticket size does play a role. Say someone's paying for braces for their children — that's a sizable purchase. Usually they'd rather not use up their general purpose card capacity on something like that, which is exactly where CareCredit fits in. And you can do it as an equal pay installment loan, or as a promotional financing product, and the revolve rates we see there tend to be quite strong too.
Mihir Bhatia
analystPerhaps to kick things off, I was hoping you might offer some perspective on your current view of buy now, pay later. What I have in mind is mainly the Pay in 4 style offering rather than bigger-ticket items where, as in Payment Solutions, you essentially provide a buy now, pay later option. My focus is really on the smaller-ticket Pay in 4. What's your thinking there? Are you looking at that? Should we anticipate seeing you launch something along those lines? Is there any timeline you can provide?
Brian Doubles
executiveYes. Look, I can tell you this much: it's certainly going to be a product we bring to market. We'll have something available to market alongside a couple of partners later this year. To step back and frame it more broadly, our approach is genuinely about delivering a complete suite of offerings. Our partner base is so varied that a single approach fitting everyone simply isn't possible. We need to be able to provide revolving products; short-dated installment; longer-term installment; equal pay products; buy now, pay later products. And we want to deliver that in a manner where we can bring this complete suite to our partners and essentially let them pick which offerings suit their customers best, based not only on their customer, but on what kinds of products they sell. So as you'd expect, bigger-ticket items lean more toward a longer-term installment, which can sit on a revolving product or closed end. And smaller ticket tends to be shorter term, whether through something like SetPay or a Pay in 4 style product. So that's essentially the approach: supply that comprehensive suite of offerings, then take it to our partners and really let them choose from that menu regarding what fits their customer needs based on the products they sell in their strategy.
Mihir Bhatia
analystAll right. As for timelines or additional details — I suppose I'll set that aside and continue. I simply hoped to get some clarity. Regarding what you said about loan balances, I wanted to confirm I grasped it correctly. In your view, have loan balances hit bottom, or are they quite near that point? What I'm really trying to ask is whether you anticipate additional strain from payment rates in 2Q, or whether you believe those balances will begin climbing from here. And should you have observed anything during April that you're able to discuss, that would be excellent.
Brian Wenzel
executiveYes. Thank you, Mihir. So I believe that when you consider how April began, elevated payment rates relative to the historical average remain something we keep observing, and that figure has tended to decline somewhat; we anticipate it will dissipate over the course of this quarter. Thus, when it comes to a trough in loan receivables, my expectation is that we will reach that point here. Without question, sales during roughly the first 20 days of April have been very strong. Consequently, our hope is that we hit the bottom here in the second quarter and then start that upward acceleration.
David Scharf
analystI appreciate you fitting me in. Brian, I had one follow-up regarding CareCredit. The bulk of the questions have already been covered. Could you give us a bit more detail, perhaps more granularity or specificity, on the way this payment product gets marketed and how awareness gets built for the shift toward procedures that are more nonelective in nature? I have noticed CareCredit displays sitting on counters at vets and at other elective locations, but what I am attempting to figure out is, as someone who belongs to a big health care system, how would I ever learn that this exists as a way to pay, and how will it be marketed in my direction?
Brian Doubles
executiveYes. Much of it comes down to — once more, this business was built by us across many decades, and much of it comes down to awareness right at the point of sale. So while you are seated in the waiting room before a vet appointment or a dental appointment, the promotional financing offer is visible to you, CareCredit is visible to you; we in fact discuss it with the providers and discuss what advantages it brings. And so that channel is the main one and has at minimum been the case historically. There is also a provider locator that we offer. And what we are attempting to do is shift things a bit further up funnel, so that when you are booking your appointment, since much of that now takes place online, what actually happens is — the promotional financing offer is being seen by you, so that this turns into, in a sense, part of the way you are thinking about your treatment. So it is not only after you arrive at your appointment that you first learn of it; you can in fact move through the entire process long before your appointment and consider how you will pay for braces or whatever treatment you happen to be getting. And we have seen that work really well; so that brand awareness has been built by us gradually. It began mostly within the provider's office, but has definitely grown to be more digital in nature via direct marketing and other channels.
David Scharf
analystGot it — and I think you brought up MyChart at some point. I mean, again, just thinking back on — especially given the pandemic, the — what I've gone through over the last...
Brian Doubles
executiveYeah, being plugged into the practice management software system matters enormously for us. That's a genuinely key piece of the growth strategy in this area, and for health systems, or hooking up with Epic, within the dentists' and the vets' own practice management software, no matter which one they happen to use, our goal is to be fully embedded there, so it turns into part of the routine for the office manager working in that location; and as you can picture, we — with 250,000 providers, we've got a broad mix of large providers and small providers, and making sure CareCredit stays top of mind as a payment option is truly essential to that business's future growth.
David Scharf
analystUnderstood. One final question from me. On Venmo specifically, regarding the program, I'm aware you brought it up before, and it remains at a very early phase. My recollection is that you described it as somewhat surpassing your expectations right now. Could you share some detail on what share of Venmo's users are being approached at the outset? I'm simply attempting to gauge — clearly this is a demographic that skews much younger. It stands to reason that many Venmo account holders possess quite limited credit histories. I'm just looking to understand how we ought to view the potential here when it comes to the composition of existing users?
Brian Doubles
executiveYeah. There isn't anything particular I can share, yet this represents an enormous chance to reach 70 million Venmo customers. Naturally, they must satisfy our underwriting standards and pass our screen. Even so, that's simply — it's a massive chance for our company. Once more, without question this will rank among our top 10 programs. And the initial results regarding what we're observing on spend and accounts exceed our prior projections. And we had — our expectations were quite aspirational. So it's very encouraging, despite the fact that we've only been fully launched for a couple of months.
Brian Wenzel
executiveOne more thing worth mentioning, Brian — and this speaks to another advantage on our side — is that we're able to obtain information from the providers themselves. Take Venmo: if it has known someone for some stretch of time, can track how quickly they're making payments, and can see the length of their association, it can hand that data over to us. So even when the credit bureau file looks the same, the depth of what PayPal and Venmo hold can work in our favor when it comes to underwriting.
Jennifer Church
executiveVanessa, we have time for 1 more question.
Dominick Gabriele
analystI'd like to return to the overall business for a moment, and I truly appreciate all the detail you provided on CareCredit. However, when we consider CET1 and how high it might climb relative to the general purpose issuers, my understanding is that a gap has historically existed between private label CET1 levels and those of general purpose players. So, do you anticipate that gap will narrow? And have you spoken with the regulators about whether they'd be at ease with such a narrowing? Then I have one more question after that.
Brian Wenzel
executiveYes. Thank you, Dominick. I don't believe we've discussed the product itself — private label against general purpose — with them. My sense is that what they examine are the loss scenarios we model, correct, the stress scenarios we run. There's a quite distinctive element in our RSAs, and that element offers protection against a portion of the expenditures. So, in my view, when you examine what those produce, our perspective really isn't any different from that of certain competitors — take Capital One, for instance — regarding how its stress capital buffer turns out; we therefore align with them. It isn't truly about which products are involved. And certainly, on our side, during those discussions, we're really showing them how resilient this business and this customer are, since because of where the account originates, we actually achieve better yields and improved risk-adjusted returns. And once more, pairing that with the RSA cushion delivers specific strength when it comes to maintaining a reduced capital ratio. That's the nature of the discussions we're holding with them.
Dominick Gabriele
analystThat's very logical. Given each of those considerations, I'd actually make the case that on a risk-adjusted footing you ought to sit lower than the broad-market operators. Then, considering how efficiently the company runs as we go forward — clearly the loan portfolio will feel pressure from a number of directions. Sure, thanks to some tailwinds in the wider economy, you might see decent cyclical growth. Still, when it comes to GAAP, and when I consider every element tied simply to how large your loan book is, how are you viewing the company's efficiency over the long haul across the coming several years? Does efficiency stay under pressure until you return to what's perhaps your usual average loan book size? And do any dynamics exist between the credit side — CareCredit and the retail card? I'm really glad to be on this call.
Brian Doubles
executiveThank you, Dominick. Here's how I'd frame efficiency: during the prior year we carried out a strategic review. That review indicated that, looking ahead to 2025, considering the business mix I'll have, and aiming to be a company with a top ROA profile — when I examine the revenue traits, the loss content traits, the RSA traits, what must my expense and efficiency ratio be so that I rank top-tier on ROA, ahead of every one of our peers, and truly deliver that investment thesis? From there we fed it back into the plans we established during the later portion of 2020. So I believe we've set about that, and one piece of it is producing more than $210 million of benefit in the current year on the cost-out side. Honestly, what pressures the efficiency ratio more over the near term is the revenue headwind tied to net interest margin, with NII having been somewhat affected — or currently being affected — by stimulus along with really excellent credit and the late fee effect that follows from it. That represents a modest headwind. My view is you will observe this. Consider our business model: it was constructed on a base of keeping expenses at a very manageable level relative to the size of the loan balance. As CareCredit and these other businesses expand, I believe operating leverage should become achievable, since they carry higher average balances — think of the larger ticket size linked to those accounts. And what must not be overlooked is that, compared with our peers, we need not devote as much to marketing in order to generate those new accounts. So when it comes to the cost of acquiring customers, we're likely industry-best, or at least highly attractive, which genuinely gives us a competitive edge over our peers. Therefore we'll keep a tight grip on efficiency. At the same time, we'll keep funding the future of the digital assets we've deployed across the last several years. We'll keep funding our long-term future. So it amounts to a blend of investment plus having a business model and a partner set that lets us leverage it and produce that operating efficiency as we likely grow faster than peers while earning a return above the peer average — that's how I'd think about it, Dominick.
Operator
operatorThank you, everyone, and that brings our Q&A portion to a close. This marks the end of today's call, and we appreciate everyone for joining us. You're welcome to disconnect at this time.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Synchrony Financial transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Synchrony Financial earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Synchrony Financial or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.